Overview
SCS systems are developed to deliver electrical stimulation to the spinal cord for the regulation of pain signal transmission to the brain. By modulating abnormal neural signaling associated with chronic pain conditions, these systems are primarily used for the treatment of chronic, refractory pain affecting the trunk and limbs, helping alleviate pain symptoms and improve patients’ quality of life.
Following the achievement of our initial Class III medical device registration certificate from the NMPA in 2022, we have continuously broadened our SCS portfolio through successive technological upgrades and product refinements.
SCS systems deliver electrical stimulation pulses to the spinal cord via leads implanted in the epidural space, thereby modulating pain signal transmission along the spinal cord to the brain and alleviating chronic, intractable pain in the trunk and limbs. The following diagram illustrates the working mechanism of our SCS systems.
